Health
Researchers use genetics to identify potential drugs for early management of COVID-19 – News-Medical.net
A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages….
A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages.
The findings appeared online in the journal Nature Medicine in March 2021.
Based on their analyses, the researchers are calling for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2. The goal is to identify existing drugs, either FDA-approved or in clinical development for other conditions, that can be repurposed…
-
General6 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoBrisbane’s original 1979 electric trains take one last journey
-
Noosa News15 hours agoRainbow Beach surfer’s untold 7/7 story
-
General22 hours agoParis opens River Seine for public swimming for first time since 1923